What DataPathology does

DataPathology is a Casablanca-based MedTech startup founded in 2020 that operates a digital pathology platform enabling remote pathological diagnosis, primarily focused on cancer diagnosis for hospitals, clinics, and diagnostic laboratories across Morocco and Africa. The platform addresses acute shortages of trained pathologists in underserved African markets and rising cancer caseloads by digitizing slide workflows and connecting requesting institutions with remote diagnostic capacity, with stated reach spanning 14+ countries across Africa and Europe.

The company's core product offering centers on a digital pathology platform that delivers rapid and secure remote pathological diagnosis, with features described as "Remote Pathological Diagnosis" and "Digital Cancer Diagnosis Systems." Technical differentiation is framed around domain specialization in pathology and accuracy/precision in cancer diagnosis, though the input contains no disclosure of proprietary AI models, patented components, or third-party model dependencies; the platform appears to function primarily as a digital workflow and connectivity layer rather than as an AI-native diagnostic engine.

DataPathology monetizes through subscription and recurring service revenue from institutional customers under an enterprise field sales motion that targets hospitals, clinics, and diagnostic laboratories directly. The company has raised approximately $1.2 million in disclosed funding across two rounds (a ~$223K seed led by Witamax in September 2021 and a ~$982K round led by Azur Innovation Fund in May 2023), and reports a team size of 1-10 employees. Co-founders Hicham El Attar and Mohammed El Khannoussi lead the company, which operates as an independent private entity with no disclosed parent company or public listing.

Name

DataPathology

Website

https://datapathology.ma

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

DataPathology is a Casablanca-based MedTech startup operating a digital pathology platform that delivers remote pathological diagnosis, primarily for cancer, to hospitals, clinics, and diagnostic laboratories across Morocco and Africa.

Ownership category

akta.pro rank

Product category

Digital Pathology / Tele-pathology Diagnostics

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)

akta.pro secondary industry

Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Digital pathology services
• Remote cancer diagnostics
• Telepathology platform
• Pathology consultation services
• Medtech diagnostics software

Headquarters

HQ city

Casablanca

HQ country

Morocco

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Digital Pathology Diagnostic Services: Provides digital solutions for rapid and secure pathological diagnosis to hospitals, clinics, and diagnostic laboratories across Morocco and Africa

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

DataPathology provides a digital pathology platform that enables remote pathological diagnosis, offering rapid and secure digital solutions for cancer diagnosis. The platform serves hospitals, clinics, and diagnostic laboratories across Morocco and Africa, addressing the critical shortage of pathologists and rising cancer cases in underserved regions. The company operates a network of connected diagnostic centers to expand access to specialized pathology expertise.

Product overview

DataPathology offers a digital pathology platform that enables remote pathological diagnosis, providing digital solutions for rapid and secure cancer diagnosis. The company operates as a single unified product offering focused on connecting diagnostic laboratories and supporting clinical institutions facing challenges such as lack of pathologists and rising cancer cases.

Differentiator

Problem solved

Functional benefit

Products and services

• DataPathology Platform

Quantifiable outcome

• Increased network coverage for pathological diagnosis across Morocco and Africa

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• PathAI: US-based AI pathology company providing digital diagnostic solutions for cancer. Directly comparable technology stack (digital pathology + AI-assisted diagnosis) and target end market (hospitals seeking accurate, scalable cancer diagnosis), though operating at much larger scale and capital base.
• Proscia: Digital pathology platform company offering software for pathology workflows and AI-enabled cancer diagnosis. Closely comparable product category (cloud-based pathology platform serving hospitals and labs) with overlapping customer profile of clinical institutions seeking to modernize cancer diagnostics.
• Ibex Medical Analytics: Israel-based AI pathology company focused on cancer diagnosis in clinical workflows. Direct overlap on AI-augmented cancer diagnosis for hospital labs; comparable technology positioning around augmenting pathologist capacity.
• Paige.AI: Digital pathology AI company building clinical-grade diagnostic products for cancer. Directly comparable in the digital cancer diagnosis space with regulatory-cleared products serving similar hospital and reference lab customers.
• Indica Labs: Provider of digital pathology image analysis software used by research and clinical pathology labs. Comparable as a pathology software platform serving laboratories, with overlapping customer base of diagnostic centers and hospitals.

Broad incumbents

• Sectra: Swedish medical imaging IT company with a digital pathology module that integrates with hospital PACS systems. Comparable as a digital pathology vendor to hospitals, but operates as a broader imaging/IT incumbent rather than a pathology specialist.
• Philips Digital Pathology: Multinational health technology major with a digital pathology solution sold to hospitals and labs. Comparable end market and use case (scanner + workflow + remote review), but part of a much broader medtech portfolio rather than a focused pathology offering.
• Leica Biosystems (Danaher): Global pathology equipment and workflow vendor (owned by Danaher) covering slide scanners, reagents, and image management. Comparable customer base of pathology labs and hospitals, but competes via capital equipment and consumables rather than a software-first remote-diagnosis model.

Emerging players

• Owkin: AI-for-health company with pathology and oncology applications for hospitals and pharma. Partial overlap on AI-driven cancer diagnosis; broader scope into drug discovery makes it an emerging adjacent player rather than a direct pathology services competitor.

Regional players

• Hurone AI: US-based but Africa-focused oncology AI company building decision-support tools for cancer treatment in low-resource settings. Highly comparable mission (improving cancer care in underserved African contexts) and adjacent technology, making it the closest thematically aligned peer in DataPathology's geographic niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DataPathology